Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

BACKGROUND/AIMS: The clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these variables to create individual IFX treatment strategies for patients with pedi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Liver
Hlavní autoři: Choi, So Yoon, Kang, Ben, Lee, Jee Hyun, Choe, Yon Ho
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial Office of Gut and Liver 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221861/
https://ncbi.nlm.nih.gov/pubmed/27609485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16041
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky